Clinical Trials Browser

Phase 2/3 × Interventional × Urinary Bladder Neoplasms × Clear all

NCT07106762 2026-03-10

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Phase 2/3 Recruiting

Urinary Bladder Neoplasms

NCT07129993 2026-03-05

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Phase 2/3 Recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06225596 2026-02-17

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

Phase 2/3 Recruiting

Urinary Bladder Neoplasms

NCT03022825 2025-10-16

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer

Phase 2/3 Active not recruiting

190 enrolled 1 FDA

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06537154 2025-07-30

NEO-BLAST

Phase 2/3 Recruiting

Urinary Bladder Neoplasms

NCT01869413 2022-10-04

TACT

Phase 2/3 Completed

Urinary Bladder Neoplasms

NCT01438112 2021-04-14

BOND

Phase 2/3 Terminated

Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Virus Diseases

NCT02355886 2019-06-04

Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy

Phase 2/3 Completed

25 enrolled 8 charts

Urinary Bladder Neoplasms

NCT01668459 2018-12-04

CabB1

Phase 2/3 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms

NCT03427034 2018-02-09

ABSEIL

Phase 2/3 Unknown

Urinary Bladder Neoplasms, Hematuria, Recurrence

NCT01475266 2017-03-29

Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Phase 2/3 Terminated

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT00389155 2015-12-07

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Phase 2/3 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis

NCT01316874 2015-06-12

Bladder Cancer

Phase 2/3 Completed

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT00014274 2013-06-12

Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

Phase 2/3 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00006124 2013-02-13

Celecoxib in Treating Patients With Bladder Cancer

Phase 2/3 Completed

Urinary Bladder Neoplasms

NCT00330707 2011-03-04

Combined Use of BCG and Interferon Alpha in Bladder Cancer

Phase 2/3 Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms